Form 4: Amphastar Pharmaceuticals CFO William J. Peters Reports Stock Transaction
SEC Form 4
William J. Peters, CFO, EVP & Treasurer of Amphastar Pharmaceuticals, reports disposition of shares to cover tax obligations related to vesting of restricted stock units.
Summary
- On May 19, 2025, William J. Peters, CFO, EVP & Treasurer of Amphastar Pharmaceuticals, disposed of 273 shares of common stock to cover tax liabilities.
- The shares were sold at a price of $24.79.
- Following the transaction, Peters directly owns 124,985 shares of Amphastar Pharmaceuticals.
Sentiment
Score: 5
Explanation: This is a routine transaction related to tax obligations, so it has a neutral sentiment.
Industry Context
Form 4 filings are a routine part of the US stock market and are required by the SEC to provide transparency into the transactions of company insiders.
Stakeholder Impact
- The transaction has a minimal impact on stakeholders as it is a routine sale of shares to cover tax obligations.
Key Dates
| Date | Description |
|---|---|
| 05/19/2025 | Date of stock transaction |
| 05/20/2025 | Date of signature |
Keywords
Form 4, Amphastar Pharmaceuticals, William J. Peters, Stock Transaction, CFO, RSUs, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.